Targeted modulation of immune cells and tissues using engineered biomaterials

被引：62
|
作者：
Yousefpour, Parisa [1 ]
Ni, Kaiyuan [1 ]
Irvine, Darrell J. [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
[2] MIT, Dept Biol Engn, Cambridge, MA 02139 USA
[3] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA
[4] MIT, Ragon Inst Massachusetts Gen Hosp, Cambridge, MA 02139 USA
[5] Harvard Univ, Cambridge, MA 02138 USA
[6] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA
来源：
NATURE REVIEWS BIOENGINEERING | 2023年 / 1卷 / 02期
关键词：
CD8(+) T-CELLS; NEUTRALIZING ANTIBODY-RESPONSES; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; SOLID TUMORS; IN-VIVO; VASCULAR NORMALIZATION; NANOPARTICLE VACCINES; 1ST-IN-HUMAN PHASE-1; TRAINED IMMUNITY;
D O I：
10.1038/s44222-022-00016-2
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
Therapies modulating the immune system offer the prospect of treating a wide range of conditions including infectious diseases, cancer and autoimmunity. Biomaterials can promote specific targeting of immune cell subsets in peripheral or lymphoid tissues and modulate the dosage, timing and location of stimulation, thereby improving the safety and efficacy of vaccines and immunotherapies. Here, we review recent advances in biomaterials-based strategies, focusing on targeting of lymphoid tissues, circulating leukocytes, tissue-resident immune cells and immune cells at disease sites. These approaches can improve the potency and efficacy of immunotherapies by promoting immunity or tolerance against different diseases.
引用
收藏
页码：107 / 124
页数：18
相关论文
共 50 条
  • [21] Using engineered stromal cells for the targeted therapy of liver carinoma
    Fourquet, Elodie
    Muscari, Fabrice
    Peron, Jean-Marie
    Buscail, Louis
    Sicard, Flavie
    Cordelier, Pierre
    HUMAN GENE THERAPY, 2011, 22 (06) : A11 - A11
  • [22] Biomaterial-assisted targeted modulation of immune cells in cancer treatment
    Wang, Hua
    Mooney, David J.
    NATURE MATERIALS, 2018, 17 (09) : 761 - 772
  • [23] Biomaterial-assisted targeted modulation of immune cells in cancer treatment
    Hua Wang
    David J. Mooney
    Nature Materials, 2018, 17 : 761 - 772
  • [24] Engineered Cell Membrane-Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation
    Ma, Yilei
    Yi, Jia
    Ruan, Jing
    Ma, Jiahui
    Yang, Qinsi
    Zhang, Kun
    Zhang, Maolan
    Zeng, Guoming
    Jin, Libo
    Huang, Xiaobei
    Li, Jianshu
    Yang, Haifeng
    Wu, Wei
    Sun, Da
    ADVANCED HEALTHCARE MATERIALS, 2024, 13 (20)
  • [25] Manufacturing Cell Therapies Using Engineered Biomaterials
    Abdeen, Amr A.
    Saha, Krishanu
    TRENDS IN BIOTECHNOLOGY, 2017, 35 (10) : 971 - 982
  • [26] Future Trends in Biomaterials and Devices for Cells and Tissues
    De Bartolo, Loredana
    Piscioneri, Antonella
    Ramakrishna, Seeram
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [27] Printing mammalian cells for replacement tissues BIOMATERIALS
    Wood, Jonathan
    MATERIALS TODAY, 2004, 7 (06) : 18 - 18
  • [28] Immune Modulation by Transplanted Calcium Phosphate Biomaterials and Human Mesenchymal Stromal Cells in Bone Regeneration
    Humbert, Paul
    Brennan, Meadhbh A.
    Davison, Noel
    Rosset, Philippe
    Trichet, Valerie
    Blanchard, Frederic
    Layrolle, Pierre
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [29] Enhancement of angiogenesis to engineered tissues using VEGF secreting encapsulated cells
    Machluf, M
    Amiel, GE
    Soker, S
    Atala, A
    PEDIATRICS, 1999, 104 (03) : 808 - 809
  • [30] Supply of Nutrients to Cells in Engineered Tissues
    Rouwkema, Jeroen
    Koopman, Bart F. J. M.
    van Blitterswijk, Clemens A.
    Dhert, Wouter J. A.
    Malda, Jos
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, VOL 26, 2010, 26 : 163 - 177
12345